Relation Therapeutics News and Activities

View the org chart displaying its 23 main executives

Most searched biographies at Relation Therapeutics

• David Roblin, Chief Executive Officer and Director
• Charles Roberts, Chairman of the Board
• John Wesley, Director

Popular executive movements at Relation Therapeutics

• Amaia Vilas, who was Associate Director, Sequencing & Profiling, is promoted to Senior Director, Molecular Profiling & Sequencing  (posted on March 31 2026).
• Karl Gemayel, who was Associate Director of Machine Learning, is promoted to Director of Machine Learning  (posted on March 31 2026).
• Marian Chaney has joined the company as Director of People  (posted on March 31 2026).

Click here to view some more movements at Relation Therapeutics

Create your alert
to follow the executive moves at Relation Therapeutics.

Relation Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Relation Therapeutics

• Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
• The Times | GSK puts its faith in London… | Relation Therapeutics

Social media about Relation Therapeutics

• Relation Therapeutics on Wikipedia, Google News & Yahoo Finance
• Relation Therapeutics on LinkedIn, X (Twitter) & YouTube